Pricing Log in Create free account

Tevogen Inc. (TVGN) vs Veru Inc. (VERU)

Tevogen Inc. and Veru Inc. are both Biotechnology companies. Tevogen Inc. and Veru Inc. are of similar size ($36.2M and $35.1M). Across the 9 metrics below, Veru Inc. leads on 5 and Tevogen Inc. on 4.

Valuation

Metric TVGN VERU Biotechnology median
P/E n/m n/m 10.60
P/S n/m 2.65 9.40
P/B n/m 1.74 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1.44 9.02
Earnings yield (115.91%) (27.13%) (32.88%)
Free cash flow yield (56.79%) (52.80%) (23.13%)

Profitability

Metric TVGN VERU Biotechnology median
Gross margin — 43.39% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 123.10% (62.25%) (51.96%)
Return on assets (492.20%) (42.29%) (46.06%)
Return on invested capital 0.00% (464.03%) 0.00%

Growth

Metric TVGN VERU Biotechnology median
Revenue growth (TTM) — 14.18% 6.76%
EPS growth (last fiscal year) (130.86%) 44.64% 29.88%
Revenue growth, 5-year CAGR — (11.89%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric TVGN VERU Biotechnology median
Debt to equity (0.72) 0.00 0.00
Current ratio 0.33 4.42 4.97
Net debt to EBITDA (0.15) 0.74 1.01

Dividend

Metric TVGN VERU Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric TVGN VERU Biotechnology median
Market cap 36.21m 35.12m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack